Anixa Total Assets from 2010 to 2024

ANIX Stock

USD 3.32 0.10 3.11%

Anixa Biosciences Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1985-10-31

Previous Quarter

24.4 M

Current Value

22.9 M

Quarterly Volatility

731 M

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.

Check out the analysis of Anixa Biosciences Correlation against competitors.

For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Latest Anixa Biosciences' Total Assets Growth Pattern

Below is the plot of the Total Assets of Anixa Biosciences over the last few years. Total assets refers to the total amount of Anixa Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Anixa Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Anixa Biosciences' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 25.52 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Anixa Total Assets Regression Statistics

	Arithmetic Mean	14,785,759
	Geometric Mean	10,997,068
	Coefficient Of Variation	79.70
	Mean Deviation	10,457,430
	Median	9,055,356
	Standard Deviation	11,784,738
	Sample Variance	138.9T
	Range	33M
	R-Value	0.82
	Mean Square Error	48.5T
	R-Squared	0.68
	Significance	0.0002
	Slope	2,166,064
	Total Sum of Squares	1944.3T

Anixa Total Assets History

	2024	30.8 M
	2023	29.4 M
	2022	25.5 M
	2021	30.4 M
	2020	36.3 M
	2019	9.5 M
	2018	6.3 M

Other Fundumenentals of Anixa Biosciences

Intangibles To Total Assets

Anixa Biosciences Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Net Receivables	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Long Term Investments	Intangible Assets	Long Term Debt Total	Short Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	-0.55	-0.67	-0.29	0.99	-0.34	-0.61	0.81	-0.32	0.64	0.01	0.98	0.83	-0.48	-0.16	0.26	-0.49	0.95	0.95	0.92
Total Stockholder Equity	0.98		-0.59	-0.65	-0.46	1.0	-0.27	-0.63	0.8	-0.44	0.7	0.08	0.99	0.86	-0.43	-0.25	0.26	-0.55	0.93	0.94	0.92
Net Debt	-0.55	-0.59		0.29	0.41	-0.56	0.19	0.37	0.01	0.27	-0.34	0.14	-0.49	-0.46	0.03	0.26	-0.16	0.32	-0.62	-0.63	-0.37
Retained Earnings	-0.67	-0.65	0.29		0.12	-0.67	0.85	0.02	-0.59	0.34	-0.15	0.6	-0.67	-0.77	0.85	-0.08	-0.69	0.74	-0.58	-0.59	-0.67
Total Liab	-0.29	-0.46	0.41	0.12		-0.38	-0.25	0.35	-0.22	0.76	-0.59	-0.34	-0.42	-0.43	-0.09	0.51	-0.06	0.49	-0.25	-0.27	-0.32
Total Current Assets	0.99	1.0	-0.56	-0.67	-0.38		-0.3	-0.62	0.82	-0.39	0.68	0.05	0.99	0.85	-0.46	-0.2	0.27	-0.52	0.94	0.95	0.93
Net Receivables	-0.34	-0.27	0.19	0.85	-0.25	-0.3		-0.28	-0.2	0.04	0.26	0.84	-0.28	-0.41	0.81	-0.25	-0.6	0.49	-0.25	-0.27	-0.29
Accounts Payable	-0.61	-0.63	0.37	0.02	0.35	-0.62	-0.28		-0.52	0.26	-0.63	-0.55	-0.64	-0.44	-0.22	0.53	0.38	-0.06	-0.65	-0.65	-0.65
Short Term Investments	0.81	0.8	0.01	-0.59	-0.22	0.82	-0.2	-0.52		-0.29	0.59	0.19	0.86	0.71	-0.51	-0.11	0.18	-0.41	0.7	0.7	0.87
Common Stock	-0.32	-0.44	0.27	0.34	0.76	-0.39	0.04	0.26	-0.29		-0.55	-0.09	-0.43	-0.48	0.21	0.28	-0.29	0.62	-0.26	-0.28	-0.35
Property Plant Equipment	0.64	0.7	-0.34	-0.15	-0.59	0.68	0.26	-0.63	0.59	-0.55		0.54	0.71	0.57	0.04	-0.46	-0.08	-0.25	0.64	0.64	0.66
Current Deferred Revenue	0.01	0.08	0.14	0.6	-0.34	0.05	0.84	-0.55	0.19	-0.09	0.54		0.1	-0.05	0.55	-0.39	-0.54	0.36	0.06	0.05	0.13
Net Tangible Assets	0.98	0.99	-0.49	-0.67	-0.42	0.99	-0.28	-0.64	0.86	-0.43	0.71	0.1		0.86	-0.46	-0.27	0.23	-0.52	0.91	0.92	0.94
Capital Surpluse	0.83	0.86	-0.46	-0.77	-0.43	0.85	-0.41	-0.44	0.71	-0.48	0.57	-0.05	0.86		-0.53	-0.27	0.52	-0.61	0.85	0.86	0.93
Long Term Investments	-0.48	-0.43	0.03	0.85	-0.09	-0.46	0.81	-0.22	-0.51	0.21	0.04	0.55	-0.46	-0.53		-0.47	-0.78	0.72	-0.33	-0.34	-0.46
Intangible Assets	-0.16	-0.25	0.26	-0.08	0.51	-0.2	-0.25	0.53	-0.11	0.28	-0.46	-0.39	-0.27	-0.27	-0.47		0.53	-0.2	-0.24	-0.26	-0.29
Long Term Debt Total	0.26	0.26	-0.16	-0.69	-0.06	0.27	-0.6	0.38	0.18	-0.29	-0.08	-0.54	0.23	0.52	-0.78	0.53		-0.72	0.24	0.25	0.29
Short Term Debt	-0.49	-0.55	0.32	0.74	0.49	-0.52	0.49	-0.06	-0.41	0.62	-0.25	0.36	-0.52	-0.61	0.72	-0.2	-0.72		-0.36	-0.37	-0.44
Net Invested Capital	0.95	0.93	-0.62	-0.58	-0.25	0.94	-0.25	-0.65	0.7	-0.26	0.64	0.06	0.91	0.85	-0.33	-0.24	0.24	-0.36		1.0	0.91
Net Working Capital	0.95	0.94	-0.63	-0.59	-0.27	0.95	-0.27	-0.65	0.7	-0.28	0.64	0.05	0.92	0.86	-0.34	-0.26	0.25	-0.37	1.0		0.92
Capital Stock	0.92	0.92	-0.37	-0.67	-0.32	0.93	-0.29	-0.65	0.87	-0.35	0.66	0.13	0.94	0.93	-0.46	-0.29	0.29	-0.44	0.91	0.92

Click cells to compare fundamentals

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	29.4 M	30.8 M
Intangibles To Total Assets	0.15	0.28

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC